Loading...
OTC Markets
Totals
Securities
12,242
Dollar Vol
$2.4B
Share Vol
3B
Trades
343,017

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

SHMN
SOHM, Inc.

Common Stock

0.0015

-0.0001

-6.25%

No Inside Bid / Offer

Delayed (15 Min) Trade Data: 12:00am 08/22/2025

0.0016

0.0015 - 0.0016

13,000

N/A

Real-Time Level 2 Quote
Bid
Ask
MPID
MPID
Bid Price
Bid Price
Size
Size
Time
Time
ETRF
24.90>year
CDEL
21.9203/16
MACM
18.95>year
NITE
18.95>year
CSTI
18.55>year
MPID
MPID
Ask Price
Ask Price
Size
Size
Time
Time
INTL
19.40>year
NITE
19.40>year
MACM
19.43>year
MAXM
20.11>year
CANT
22.05>year
Unlock Real-Time quotes For SHMNFind Out More
Trade Data
Date
Date
Timestamp
Timestamp
Price
Price
$ Change
$ Change
Volume
Volume
08/22/202515:57:23
0.0015
0.005,000
08/22/202515:55:24
0.0015
-0.001,000
08/22/202510:57:25
0.0016
0.003,000
08/22/202510:54:34
0.0016
0.002,000
08/22/202509:30:00
0.0016
0.002,000
More Irregular/odd lot trades, which are not considered for the Open, High, Low or Closing prices, are not shown in trade data table.
Company Description
Welcome to SOHM Inc., a pioneering force in health and wellness innovation, headquartered in Chino Hills, California. With our state-of-the-art pharmaceutical and nutraceutical manufacturing facility in Carlsbad, CA, and cutting-edge biotechnology research and development center in Tucson, AZ-aligned with the esteemed University of Arizona Center for Innovation-we are on a mission to transform lives through groundbreaking science and exceptional products. One of our most exciting innovations is the ABBIE (A Binding Based Integrase Enzyme) Retroviral Integrase-dCas9 donor DNA integration system as an off-the-shelf kit for gene editing. This game-changing technology is poised to revolutionize the field of gene therapy, offering new hope for patients suffering from diseases such as cancer and genetic disorders. By simplifying the gene editing process, ABBIE enables researchers and clinicians to develop targeted therapies faster and more effectively than ever before. We believe that this groundbreaking tool will pave the way for transformative treatments, bringing us closer to a future where genetic diseases can be treated at their source. SOHM Inc. is driven by a steadfast commitment to excellence-both in personal health and biotechnological advancements. Our team of dedicated scientists and health experts tirelessly work to ensure that each product we create meets the highest standards of quality and efficacy.
Videos

This company has not added any videos

OTCID Market Logo
OTCID
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.